As part of Kuwait Ministry of Health’s endeavor to meet the local market’s demands for pharmaceutical supplies, a special partnership has been formed with the international company “Abbott Laboratories” that specializes in medical devices and healthcare, in a joint partnership agreement with Kuwait Saudi Pharmaceutical Industries (KSP), a subsidiary of Mezzan Holding. This partnership works on locally manufacturing 26 innovative products in Kuwait. Commenting on this new partnership, H.E. Dr. Ahmad Al Awadi, Minister of Health said: “This partnership supports the ministry’s goal of making Kuwait the pharmaceutical hub in the Middle East, placing great importance on the quality of medications and pharmaceutical products that it procures, securing the needs of our countryHe then added: “The welfare of our nation is our priority, and today, Kuwait will proudly have direct access to innovative and quality products that cater to the local needs, while also benefiting from the knowledge we will be gaining. Ultimately, investments from multinational companies such as Abbott not only contribute to the well-being of our local community, but also to the diversification and growth of Kuwait’s economy in line with its New Kuwait Vision 2035. We’re here today, proudly witnessing a promising partnership between Abbott and KSP (subsidiary of Mezzan Holding KSCP), a leading Kuwaiti pharmaceutical firm.The partnership marks a milestone for Kuwait with an international pharmaceutical company investing in local manufacturing. The agreement was facilitated and supported by Kuwait Ministry of Health and the US Embassy. By localizing the manufacturing, Kuwait will have easier and faster access to these products, while also benefiting from transfer of technologies, employment opportunities and training programs to handle the most up-to-date equipment and tools (ICE KUWAIT)

Fonte notizia: ARAB TIMES